Tectonic Therapeutic (TECX) Common Equity (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Common Equity of $230.4 million for Q1 2026, down 23.46% year-over-year from $301.0 million in Q1 2025, and down 8.32% quarter-over-quarter from $251.3 million in Q4 2025.
Tectonic Therapeutic (TECX) Common Equity (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Common Equity for 10 consecutive years, with $230.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 23.46% year-over-year to $230.4 million; the TTM figure through Mar 2026 stood at $230.4 million (down 23.46% YoY), while the FY2025 annual figure was $251.3 million, up 78.53% from the prior year.
- Common Equity slipped to $230.4 million in Q1 2026 per TECX's latest filing, from $251.3 million in the prior quarter.
- Across five years, Common Equity topped out at $301.0 million in Q1 2025 and bottomed at -$99.6 million in Q1 2024.
- Historically, Common Equity has averaged $100.7 million across 5 years, with a median of $140.8 million in 2024.
- Annual changes were most pronounced in 2023 — Common Equity slumped 181.33% — and 2025, when it jumped 402.32%.
- Tectonic Therapeutic's Common Equity stood at -$45.7 million in 2022, then sank by 85.39% to -$84.6 million in 2023, then jumped by 266.33% to $140.8 million in 2024, then jumped by 78.53% to $251.3 million in 2025, then declined by 8.32% to $230.4 million in 2026.
- Business Quant data shows TECX's Common Equity at $230.4 million in Q1 2026, $251.3 million in Q4 2025, and $267.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 223.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 223.85 Mn |
| Mar 31, 2026 | 230.42 Mn |
| Dec 31, 2025 | 251.33 Mn |
| Sep 30, 2025 | 267.53 Mn |
| Jun 30, 2025 | 283.77 Mn |
| Mar 31, 2025 | 301.04 Mn |
| Dec 31, 2024 | 140.78 Mn |
| Sep 30, 2024 | 150.36 Mn |
| Jun 30, 2024 | 166.37 Mn |
| Mar 31, 2024 | -99.57 Mn |
| Dec 31, 2023 | -84.64 Mn |
| Sep 30, 2023 | -79.78 Mn |
| Jun 30, 2023 | -70.00 Mn |
| Mar 31, 2023 | -59.82 Mn |
| Dec 31, 2022 | -45.65 Mn |
| Sep 30, 2022 | 98.09 Mn |
| Jun 30, 2022 | 118.34 Mn |
| Mar 31, 2022 | 143.16 Mn |
| Dec 31, 2021 | 169.48 Mn |
| Sep 30, 2021 | 193.57 Mn |